FDA approval of anaemia drug provides boost to Amgen
The US Food and Drug administration approved Amgen's drug Aranesp for use in chemotherapy patients who have developed anaemia, a move that could generate an additional $1bn-$2bn a year in
The US Food and Drug administration approved Amgen's drug Aranesp for use in chemotherapy patients who have developed anaemia, a move that could generate an additional $1bn-$2bn a year in